New classification of leukemic cells by using of biotecnology (Differential expression of selected genes in human leukemia leukocytes)

利用生物技术对白血病细胞进行新分类(人白血病白细胞中选定基因的差异表达)

基本信息

  • 批准号:
    60570293
  • 负责人:
  • 金额:
    $ 0.9万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1985
  • 资助国家:
    日本
  • 起止时间:
    1985 至 1986
  • 项目状态:
    已结题

项目摘要

Human leukemias are considered monoclonal disease viewed as impairing the hematopoietic cell differentiation process. It is reasonable to except that such impairment would be reflect in quantiative changes in mRNA. By using recombinant DNA technology to prepare a cloned library of expressed gene sequences discrete RNA species present in differential amounts in normal and malignant cells can now be examined. The relative abundance of a clonal sequence of cellular RNA can be estimated by nucleic acid hybridization. Selected and analysis of clones containing copies of cDNA transcripts of mRNA was accomplised as shown below.1.Preparation of cDNA library from total mRNA of CLL cells. And screening of library with [ <^(32)P> ]-cDNA from CLL and placental cells. Selection of 21 clones that react positively with [ <^(32)P> ]-cDNA from CLL but do not react with [ <^(32)P> ]-cDNA from placental cells.2.The use of these DNA segments to measure the population of mRNA for neoplastic cell specific expressed genes in various leukemic cells by Dot blot hybridization method.3.Determination of DNA sequence of cDNA insert in each clone.Total cellular RNAs from a variety of hematopoietic neoplastic cells and normal lymphocytes were analyzed for homology with 21 recombinant DNA segments complementary to the specific mRNA of cells from a patiant with CLL.Twenty of the clones (except for clone 8-6G) were not significantly represented in the mRNA from normal lymphocytes. The relative concentrations of three clones (6-1E,7-3G and 9-5C) in the RNAs from a variety of normal leukemic leukocytes and human hematopoietic cell lines were measured by Northern blot hybridization. This showed that 7-3G,6-1G and 9-5C RNA were highly abundant in RNA from hematopoietic neoplastic leukocytes. Also, clone 7-2D was highly represented in B cell type hematopoietic neoplastic leukocytes,6-1G was highly represented in Raji cell while clone 6-1E was highly represented in Molt 3 cell.
人类白血病被认为是一种损害造血细胞分化过程的单克隆性疾病。这是合理,但这种损害将反映在定量变化的信使核糖核酸。通过使用重组DNA技术准备表达基因序列的克隆文库,现在可以检测正常细胞和恶性肿瘤细胞中存在的不同数量的离散RNA物种。细胞RNA克隆序列的相对丰度可以通过核酸杂交来估计。如下所示:1.从CLL细胞的总mRNA中制备cDNA文库。从CLL和胎盘细胞中筛选含[&lt;^(32)P&gt;]-cDNA文库。从CLL中筛选出与[&lt;^(32)P&gt;]-cDNA呈阳性反应但不与[&lt;^(32)P&gt;]反应的21个克隆。2.利用这些DNA片段通过斑点杂交法测定不同白血病细胞中肿瘤细胞特异性表达基因的mRNA群体。3.每个克隆插入的DNA序列的测定。对来自各种造血肿瘤细胞和正常淋巴细胞的细胞总RNA进行同源性分析,其中21个重组DNA片段与一名CLL患者细胞的特异性mRNA互补,其中20个克隆(克隆8-6G除外)在正常淋巴细胞的mRNA中没有显著表达。用Northern印迹杂交法测定了3个克隆(6-1E、7-3G和9-5C)在多种正常白血病细胞和人造血细胞系的RNA中的相对浓度。这表明7-3G、6-1G和9-5C RNA在造血肿瘤白细胞的RNA中高度丰富。克隆7-2D在B细胞型造血肿瘤细胞中高表达,6-1G在Raji细胞中高表达,6-1E在Molt3细胞中高表达。

项目成果

期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hiroshi Masuno;Takahiko Shiosaka;Yoshinobu Ito;Morikazu Onji;Yasuyuki Ohta;Hiromichi Okuda: Jpn.J.Cancer Res.(Gann). 76. 202-207 (1985)
Hiroshi Masuno;Takahiko Shiosaka;Yoshinobu Ito;Morikazu Onji;Yasuyuki Ohta;Hiromichi Okuda:Jpn.J.Cancer Res.(江恩)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takahiko Shiosaka;Grady F.Saunders: Proc.Natl.Acad.Sci.USA. 79. 4668-4671 (1982)
Takahiko Shiosaka;Grady F.Saunders:Proc.Natl.Acad.Sci.USA。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yoshinobu Tanaka;Takahiko Shiosaka;Ikuya Sakai;Yuzuru Kobayashi: ACTA HAEMATOL.Jpn.50.
田中吉信;盐坂贵彦;酒井郁也;小林结弦:ACTA HAEMATOL.Jpn.50。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
奥田拓道,澄田道博,塩坂孝彦,田中理延,濱田稔: 筋ジストロフィー症解明のための遺伝子発現の基礎的研究 野々村班昭和61年度報告書. (1987)
Takumichi Okuda、Michihiro Sumita、Takahiko Shiosaka、Rinobu Tanaka、Minoru Hamada:阐明肌营养不良症的基因表达基础研究 (1987)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yoshinobu Tanaka, Takahiko Shiosaka,Ikuya Sakai and Yuzuru Kobayashi: "Expression of selected genes in human hematopoietic cells." ACTA HAEMATOL.Jpn.50.
Yoshinobu Tanaka、Takahiko Shiosaka、Ikuya Sakai 和 Yuzuru Kobayashi:“人类造血细胞中选定基因的表达”。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHIOSAKA Takahiko其他文献

SHIOSAKA Takahiko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHIOSAKA Takahiko', 18)}}的其他基金

Differential expression between proliferative and differentiative suclones from the acute myelomonoblastic leukemia cell line(ME-1)
急性粒细胞白血病细胞系(ME-1)增殖型和分化型suclon之间的差异表达
  • 批准号:
    06672310
  • 财政年份:
    1994
  • 资助金额:
    $ 0.9万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
New classification of leukaemic cells by using of biotecnology. (Differential expression of selected genes in human leukaemia leukocytes)
利用生物技术对白血病细胞进行新分类。
  • 批准号:
    62570289
  • 财政年份:
    1987
  • 资助金额:
    $ 0.9万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Define the oncogenic role of METTL3 in the pathogenesis of chronic lymphocytic leukemia
定义 METTL3 在慢性淋巴细胞白血病发病机制中的致癌作用
  • 批准号:
    10717803
  • 财政年份:
    2023
  • 资助金额:
    $ 0.9万
  • 项目类别:
A combination strategy to target pathophysiology of chronic lymphocytic leukemia
针对慢性淋巴细胞白血病病理生理学的组合策略
  • 批准号:
    10577652
  • 财政年份:
    2023
  • 资助金额:
    $ 0.9万
  • 项目类别:
Predictive markers for personalized therapy in chronic lymphocytic leukemia
慢性淋巴细胞白血病个体化治疗的预测标记
  • 批准号:
    10591089
  • 财政年份:
    2023
  • 资助金额:
    $ 0.9万
  • 项目类别:
Curing Through Collaboration: Utilizing Cooperative Groups in the Fight Against Chronic Lymphocytic Leukemia and B-cell Lymphomas
通过合作进行治愈:利用合作团体对抗慢性淋巴细胞白血病和 B 细胞淋巴瘤
  • 批准号:
    10566833
  • 财政年份:
    2023
  • 资助金额:
    $ 0.9万
  • 项目类别:
Curing Through Collaboration: Utilizing Cooperative Groups in the Fight Against Chronic Lymphocytic Leukemia and B-cell Lymphomas
通过合作进行治愈:利用合作团体对抗慢性淋巴细胞白血病和 B 细胞淋巴瘤
  • 批准号:
    10987699
  • 财政年份:
    2023
  • 资助金额:
    $ 0.9万
  • 项目类别:
Tracing the Evolution of Chronic Lymphocytic Leukemia to Richter's Syndrome: Defining Transformation
追踪慢性淋巴细胞白血病向里氏综合征的演变:定义转变
  • 批准号:
    10425791
  • 财政年份:
    2022
  • 资助金额:
    $ 0.9万
  • 项目类别:
Optimizing novel agent combination therapy for previously untreated, high risk chronic lymphocytic leukemia
优化针对先前未治疗的高风险慢性淋巴细胞白血病的新药联合疗法
  • 批准号:
    10522611
  • 财政年份:
    2022
  • 资助金额:
    $ 0.9万
  • 项目类别:
Optimizing novel agent combination therapy for previously untreated, high risk chronic lymphocytic leukemia
优化针对先前未治疗的高风险慢性淋巴细胞白血病的新药联合疗法
  • 批准号:
    10705268
  • 财政年份:
    2022
  • 资助金额:
    $ 0.9万
  • 项目类别:
The genetic and epigenetic etiology of progression from the precursor state to chronic lymphocytic leukemia (CLL)
从前体状态进展为慢性淋巴细胞白血病(CLL)的遗传和表观遗传病因学
  • 批准号:
    10369783
  • 财政年份:
    2022
  • 资助金额:
    $ 0.9万
  • 项目类别:
The genetic and epigenetic etiology of progression from the precursor state to chronic lymphocytic leukemia (CLL)
从前体状态进展为慢性淋巴细胞白血病(CLL)的遗传和表观遗传病因学
  • 批准号:
    10699957
  • 财政年份:
    2022
  • 资助金额:
    $ 0.9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了